Erika B-Cure Laser Ltd (TLV: BCUR)

Market Cap	19.48M
Revenue (ttm)	32.88M
Net Income (ttm)	-9.85M
Shares Out	104.17M
EPS (ttm)	-0.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	142,290
Open	18.20
Previous Close	18.20
Day's Range	17.00 - 18.20
52-Week Range	16.90 - 45.00
Beta	1.45
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 28, 2024

About Erika B-Cure Laser

Erika B-Cure Laser Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It offers B-Cure Laser Classic, a home medical device for the treatment of pain, orthopedic problems, dermatology, analgesia, inflammation, and wound healing; and B-Cure Laser Pro, a device for the treatment of acute and chronic problems, such as orthopedic problems, diabetic wounds, and difficulties in healing and mucositis. The company also provides B-Cure Laser Sport, a home device for treating injuries and ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2007
• Employees: 40
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: BCUR

Financial Performance

In 2023, Erika B-Cure Laser's revenue was 29.88 million, a decrease of -40.62% compared to the previous year's 50.32 million. Losses were -19.22 million, -40.97% less than in 2022.